rs7756516
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001300790.2(HLA-DQB2):c.*313G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 421,676 control chromosomes in the GnomAD database, including 58,260 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.50 ( 19803 hom., cov: 32)
Exomes 𝑓: 0.52 ( 38457 hom. )
Consequence
HLA-DQB2
NM_001300790.2 3_prime_UTR
NM_001300790.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.913
Publications
53 publications found
Genes affected
HLA-DQB2 (HGNC:4945): (major histocompatibility complex, class II, DQ beta 2) HLA-DQB2 belongs to the family of HLA class II beta chain paralogs. Class II molecules are heterodimers consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. They play a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). Polymorphisms in the alpha and beta chains specify the peptide binding specificity, and typing for these polymorphisms is routinely done for bone marrow transplantation. However this gene, HLA-DQB2, is not routinely typed, as it is not thought to have an effect on transplantation. There is conflicting evidence in the literature and public sequence databases for the protein-coding capacity of HLA-DQB2. Because there is evidence of transcription and an intact ORF, HLA-DQB2 is represented in Entrez Gene and in RefSeq as a protein-coding locus. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HLA-DQB2 | NM_001300790.2 | c.*313G>A | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000437316.7 | NP_001287719.1 | ||
| HLA-DQB2 | NM_001198858.2 | c.*313G>A | 3_prime_UTR_variant | Exon 5 of 5 | NP_001185787.1 | |||
| HLA-DQB2 | XM_011514560.3 | c.*313G>A | 3_prime_UTR_variant | Exon 5 of 5 | XP_011512862.1 | |||
| HLA-DQB2 | XM_011514561.4 | c.*313G>A | 3_prime_UTR_variant | Exon 4 of 4 | XP_011512863.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HLA-DQB2 | ENST00000437316.7 | c.*313G>A | 3_prime_UTR_variant | Exon 6 of 6 | 6 | NM_001300790.2 | ENSP00000396330.2 | |||
| HLA-DQB2 | ENST00000435145.6 | c.*1094G>A | 3_prime_UTR_variant | Exon 5 of 5 | 6 | ENSP00000410512.2 | ||||
| HLA-DQB2 | ENST00000411527.5 | c.*313G>A | 3_prime_UTR_variant | Exon 5 of 5 | 6 | ENSP00000390431.1 | ||||
| HLA-DQB2 | ENST00000427449.1 | c.*313G>A | downstream_gene_variant | 6 | ENSP00000415997.1 |
Frequencies
GnomAD3 genomes AF: 0.499 AC: 75753AN: 151908Hom.: 19773 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
75753
AN:
151908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.522 AC: 140818AN: 269648Hom.: 38457 Cov.: 0 AF XY: 0.527 AC XY: 72900AN XY: 138254 show subpopulations
GnomAD4 exome
AF:
AC:
140818
AN:
269648
Hom.:
Cov.:
0
AF XY:
AC XY:
72900
AN XY:
138254
show subpopulations
African (AFR)
AF:
AC:
3568
AN:
9318
American (AMR)
AF:
AC:
6020
AN:
10380
Ashkenazi Jewish (ASJ)
AF:
AC:
5289
AN:
9536
East Asian (EAS)
AF:
AC:
16339
AN:
22590
South Asian (SAS)
AF:
AC:
7168
AN:
11928
European-Finnish (FIN)
AF:
AC:
9817
AN:
17906
Middle Eastern (MID)
AF:
AC:
846
AN:
1328
European-Non Finnish (NFE)
AF:
AC:
83078
AN:
169564
Other (OTH)
AF:
AC:
8693
AN:
17098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2845
5690
8536
11381
14226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.499 AC: 75843AN: 152028Hom.: 19803 Cov.: 32 AF XY: 0.509 AC XY: 37827AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
75843
AN:
152028
Hom.:
Cov.:
32
AF XY:
AC XY:
37827
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
16145
AN:
41436
American (AMR)
AF:
AC:
8459
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1936
AN:
3470
East Asian (EAS)
AF:
AC:
4199
AN:
5186
South Asian (SAS)
AF:
AC:
3285
AN:
4814
European-Finnish (FIN)
AF:
AC:
6098
AN:
10562
Middle Eastern (MID)
AF:
AC:
189
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33791
AN:
67960
Other (OTH)
AF:
AC:
1118
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1875
3750
5626
7501
9376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2446
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.